Buy These 2 Small-Cap Stocks Before They Rebound

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

There's a certain thrill involved with holding small cap stocks in your portfolio. After all, given the relatively tiny size of their underlying businesses, these are the stocks which often hold the greatest prospects for growth over the long run.

To be sure, who wouldn't love to see his or her portfolio explode to the upside as today's small caps become tomorrow's massively profitable industry giants?

So what's the catch? Small-cap stocks tend to be much more volatile than their larger brethren. As a result, as long as nothing has happened to significantly change your buying thesis, you need to be willing to stick it out through thick and thin to realize truly substantial long-term gains.

With that in mind, here are two small cap stocks which are trading significantly below their 52-week-highs, and why I think you should buy them before they bounce back:

Company Market Cap % Below 52-Week-High Recent Price CAPS Rating
(out of five)
 InvenSense (NYSE: INVN  ) $854 million 45% $10.15 *****
 MAKO Surgical (UNKNOWN: MAKO.DL  ) $532 million 74% $11.27 *****

Source: Motley Fool CAPS

Sensing long-term opportunity
First up, shares of motion sensor specialist InvenSense (NYSE: INVN  ) are still reeling from a number of disappointing earnings reports and downgrades over the past year. The most recent "bad" news came from analysts at Maxim three weeks ago, who maintained their "Buy" rating on the stock, but lowered its price target to $12 per share, from $17. Even if Maxim is justified in its downgrade, however, I'm betting it's difficult to find too many investors who wouldn't be happy with an 18% gain should the stock reach the stated target

What's more, InvenSense boasts strong free cash flow, and a sterling balance sheet, with $193 million in cash and no debt. In addition, its shares currently trade at 20 times trailing earnings and just 13.5 times forward estimates -- a perfectly reasonable premium for a small-cap stock whose products have the potential to play an integral part in the fast-growing global market for mobile device sensors.

Robotic-assisted profits
I've made no secret of my optimism for shares of MAKO Surgical (UNKNOWN: MAKO.DL  ) , despite the company's gut-wrenching fall from grace over the past year; 2012 included one particularly brutal quarterly earnings report, which caused a single day drop of as much as 37%. Now, I'm a patient guy, but I have to admit that that one definitely made me think twice about selling what still remains one of my largest personal holdings. 

On one hand, MAKO management had undoubtedly overestimated its ability to sell expensive robotic surgery equipment to hospitals during one of the most challenging economic environments in recent history. As a result, they lost plenty of rapport with investors after twice being forced to lower their system sales guidance.

Even still, I remain convinced MAKO's punishment doesn't fit the crime, especially after management provided some solid answers to wary investors' questions during its most recent quarterly earnings call.

Foolish final thoughts
When the rubber hits the road, I think InvenSense and MAKO both represent fantastic small-cap stocks for patient long-term investors. If you can take the heat, these companies may just be able to help you absolutely thrash the broader market's returns.

However, if you'd still like to learn more about MAKO, analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future for the medical robotics company. Claim your copy by clicking here now.

Read/Post Comments (0) | Recommend This Article (13)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2357213, ~/Articles/ArticleHandler.aspx, 9/27/2016 12:11:20 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,176.02 81.19 0.45%
S&P 500 2,154.70 8.60 0.40%
NASD 5,284.99 27.50 0.52%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 11:55 AM
INVN $7.24 Down -0.06 -0.82%
InvenSense CAPS Rating: *****
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****